.svg){kind=small}
Oct-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
C Minor has demonstrated a promising upward trajectory in the Capsules category within Ontario. Starting from a rank of 15 in July 2025, the brand has consistently climbed the rankings, reaching 12 by October 2025. This steady ascent is mirrored by a corresponding increase in sales, which saw a notable jump from $18,552 in July to $29,338 by October. This suggests a growing consumer preference and a strengthening market presence for C Minor in this category. However, the absence of C Minor in the top 30 rankings in other states or provinces indicates potential areas for growth and expansion.
The performance of C Minor in Ontario's Capsules category is indicative of a successful strategy, perhaps driven by product innovation or effective market penetration tactics. The consistent rise in rank and sales over the months highlights the brand's ability to capture and maintain consumer interest. While the brand's absence from the top 30 in other locations might be seen as a drawback, it also presents an opportunity for C Minor to explore new markets and categories. This could provide a pathway for further growth and diversification across the broader cannabis market.
Competitive Landscape
In the Ontario capsules market, C Minor has demonstrated a steady upward trajectory in its rankings over the past few months, moving from 15th place in July 2025 to 12th place by October 2025. This consistent improvement is indicative of a positive sales trend, with C Minor's sales figures showing a significant increase from July to October. In contrast, Dosecann, a notable competitor, has seen a slight decline in its ranking, dropping from 9th to 10th place, alongside fluctuating sales. Meanwhile, Frank experienced a decline in both rank and sales, falling from 12th to 14th place by October. Interestingly, Rosin Heads has shown a strong performance, climbing to 11th place, which suggests a competitive landscape. However, C Minor's consistent rise in rank and sales positions it favorably against these competitors, indicating a strengthening market presence and potential for continued growth.
Notable Products
In October 2025, the top-performing product from C Minor was CBD Fast Acting 50 Max Softgels 30-Pack (1500mg CBD) in the Capsules category, maintaining its number one ranking consistently from July through October, with sales reaching 865 units. CBD 50 Max 3000 Oil Drops (60ml) in the Oil category climbed to the second position, improving from the fourth rank in September, with a notable increase in sales to 46 units. CBD Isolate 100 Max 3000 Oil (30ml) remained steady at the second rank until October, when it was overtaken and held the third position. CBG:CBD 1:2 Max 2250 Ultra Formula Oil (30ml) consistently maintained its third position from August through October. Fast Acting Max Softgels 30-Pack (300mg) showed improvement, rising to fourth place in October, after being absent in August and ranked fifth in July and September.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
